New immunology data for INO-3107 supporting proposed mechanism of action presented at several recent conferences Data showed ability of INO-3107 to induce an antigen-specific cytotoxic T cell response ...

The Danbury Health and Human Services team is collaborating with the Norwalk Health Department to promote three significant ...

Conference Call and Webcast Today at 4:30 p.m. ET Development Program Highlights and Anticipated Milestones Ovaprene® hormone ...

A WORRYING amount of Brits are developing mouth cancer, with a new report warning of record-breaking cases. Some 10,825 ...

Kronos Bio has given up on its only drug in clinical trials after some patients suffered neurological problems like ...

A recent health awareness program at MD Public School in Varanasi, organized by IMS BHU and Mamta Health Institute, educates adolescent girls on menstrual hygiene, balanced nutrition, and the ...

PDS Biotechnology shares declined after it issued an update about a cancer study with a combination of Versamune HPV and pembrolizumab and reported quarterly results. The stock was down 18%, to $2.25, ...

It's long been known HPV can impact women's fertility, but a new study suggests it could be causing some men's struggles too.

Researchers stressed that HPV is one of the biggest risk factors for mouth cancer. According to Cancer Research UK, 70 per ...

In October 2024, we provided updated results from our IMMUNOCERV Phase 2 clinical trial in locally advanced cervical cancer patients treated with Versamune ® HPV and chemoradiotherapy presented at the ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

In ex vivo primary cell models, the authors demonstrated that p300 KAT inhibition by KB-7898 modulated proinflammatory ...